COMP <GO>
TBI vs AMZN // RSI-14 & 200D SMA MOMENTUM
TrueBlue Inc. (NYSE) VS. Amazon.com, Inc. (NASDAQ) • 15-METRIC TALLY: TBI 2
— AMZN 4
▲ RSI-14 & 200D SMA MOMENTUM LEADER: TBI
LAST: $9.76 (+0.41%) • MKT CAP: $297.1M
rsi-technicals
60.6
LAST: $243.79 (-4.25%) • MKT CAP: $2.63T
rsi-technicals
47.2
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TBI VS. AMZN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | TBI | AMZN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 22.80% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -11.70% | 17.61% | -29.31 | AMZN | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 15.8x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -24.81% | -1.81% | -23.00 | AMZN | /fcf-yield <GO> |
| Operating Margin | -2.90% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | -3.00% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.73 | 3.32 | +0.41 | TBI | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 6/9 | -3.00 | AMZN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 6.73% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 60.6 | 47.2 | +13.40 | TBI | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.46 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 21.7x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $297.1M | $2.63T | -$2.63T | AMZN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | TBI REV | AMZN REV | TBI GROSS % | AMZN GROSS % | TBI FCF | AMZN FCF |
|---|---|---|---|---|---|---|
| FY 2026 | — | $0 | — | — | — | -$46.89B |
| FY 2025 | $1.62B | $0 | 22.8% | — | -$73.7M | $10.56B |
| FY 2024 | $1.57B | $0 | 25.9% | — | -$41.2M | $42.95B |
| FY 2023 | $0 | $0 | — | — | $34.8M | $16.92B |
| FY 2022 | — | $0 | — | — | — | -$26.32B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TBI // BETA —
AMZN // BETA 1.46